1. 2022-RA-1088-ESGO Chitinase response after 3 cycles of chemotherapy as a promising marker of chemosensitivity an ancillary analysis of the GINECO-ENGOT EWOC-1 trial. (20th October 2022) Authors: Chikh, Karim; Cuerq, Charlotte; Valero, Marie; Colomban, Olivier; Savoye, Aude-Marie; Berton, Dominique; Stefani, Laëtitia; Fabbro, Michel; Blonz, Cyriac; Tredan, Olivier; Noblecourt, Margot; Cojocarasu, Oana; Mollon-Grange, Delphine; Barlesi, Fabrice; Pujade-Lauraine, Eric; Freyer, Gilles; You, ... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A296 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2022-RA-1134-ESGO First real-life data on niraparib maintenance in newly-diagnosed advanced ovarian cancer: a descriptive analysis of the Temporary Authorisation for Use (ATU) cohort. (20th October 2022) Authors: Rouge, Thibault de la Motte; Selle, Frédéric; Kfoury, Maria; Fumet, Jean-David; Frenel, Jean-Sébastien; Wasserman, Johanna; Largillier, Rémy; Fages, Anne; Jacquemin, Virginie; Mouaddin, Nadia El; Haddad, Leïla; Tessier, Christophe; Follana, Philppe; Berton, Dominique; Floquet, Anne; Prulhiere, Ka... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A303 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 2022-RA-1144-ESGO Management of immune-related adverse events in patients with solid tumours treated with dostarlimab in the GARNET study. (20th October 2022) Authors: Berton, Dominique; Andre, Thierry; Oaknin, Ana; Moreno, Victor; Trigo, José; Curigliano, Giuseppe; Tinker, Anna V; Boni, Valentina; Barretina-Ginesta, Maria Pillar; Pikiel, Joanna; Pothuri, Bhavana; Mirza, Mansoor R; Panovcova, Petra; Duan, Tao; Dabrowski, Christine; Dabrowski, Christine; Zografo... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A204 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 2022-RA-605-ESGO Long term quality of life after chemotherapy among rare ovarian cancer survivors: the national gineco case-control Vivrovaire Rare Tumors study. (20th October 2022) Authors: Joly, Florence; Ray-Coquard, Isabelle Laure; Floquet, Anne; Lefèvre-Arbogast, Sophie; Selle, Frederic; Berton, Dominique; Frank, Sophie; Rouge, Thibault De La Motte; Kalbacher, Elsa; Provansal, Magali; Lortholary, Alain; Orfeuvre, Hubert; Alexandre, Jerome; Augereau, Paule; Nadeau, Cédric; Kurtz,... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A393 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 2022-RA-823-ESGO FOXL2 mutation detection in circulating tumor DNA of adult granulosa cell tumors as a potential biomarker for disease monitoring from the randomized ALIENOR trial, a GINECO study. (20th October 2022) Authors: Treilleux, Isabelle; Lainé, Alexandra; Combaret, Valérie; Dalban, Cécile; Gladieff, Laurence; Chevalier, Hortense; Provansal, Magali; Kurtz, Jean-Emmanuel; Brocard, Fabien; Selle, Frédéric; Heudel, Pierre Etienne; Pautier, Patricia; Fabbro, Michel; Floquet, Anne; Berton, Dominique; Savoye, Aude-M... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A267 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 2022-RA-945-ESGO Antitumour activity of dostarlimab by PD-L1 and tumour mutation burden in patients with mismatch repair deficient and proficient tumours in the GARNET trial. (20th October 2022) Authors: Banerjee, Susana; André, Thierry; Berton, Dominique; Ellard, Susan L; Jimenez, Begoña; Samouëlian, Vanessa; Gilbert, Lucy; Boni, Valentina; Han, Xinwei; Antony, Grace; Veneris, Jennifer; Oaknin, Ana Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A410 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 6/#455 Management of immune-related adverse events in patients with solid tumors treated with dostarlimab in the garnet study. (4th December 2022) Authors: Banerjee, Susana; Andre, Thierry; Berton, Dominique; Oaknin, Ana; Moreno, Victor; Trigo, José; Curigliano, Giuseppe; Tinker, Anna; Boni, Valentina; Barretina-Ginesta, Maria Pilar; Pikiel, Joanna; Pothuri, Bhavana; Mirza, Mansoor; Panovcova, Petra; Duan, Tao; Dabrowski, Christine; Zografos, Elefth... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Impact of consolidation chemotherapy after delayed complete surgery in advanced epithelial ovarian cancer: a propensity score analysis. Issue 1 (14th December 2022) Authors: Godfroy, Marine; Loaec, Cécile; Berton, Dominique; Guérin-Charbonnel, Catherine; Classe, Jean-Marc Journal: International journal of gynecological cancer Issue: Volume 33:Issue 1(2023) Page Start: 94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. O025/#522 Maintenance olaparib rechallenge in patients with ovarian cancer previously treated with a parp inhibitor: patient-reported outcomes from the phase IIIB OReO/engot-ov38 trial. (4th December 2022) Authors: Redondo, Andrés; Follana, Philippe; Scambia, Giovanni; Asselain, Bernard; Marmé, Frederik; Mirza, Mansoor; Laudani, Maria Elena; Mądry, Radosław; Glasspool, Rosalind; You, Benoit; Rubio-Perez, María Jesús; Zamagni, Claudio; El-Balat, Ahmed; Hardy-Bessard, Anne Claire; Oaknin, Ana; Ronzino, Grazia... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Symptom burden and quality of life with chemotherapy for recurrent ovarian cancer: the Gynecologic Cancer InterGroup-Symptom Benefit Study. Issue 6 (27th January 2022) Authors: Lee, Yeh Chen; King, Madeleine T; O'Connell, Rachel L; Lanceley, Anne; Joly, Florence; Hilpert, Felix; Davis, Alison; Roncolato, Felicia T; Okamoto, Aikou; Bryce, Jane; Donnellan, Paul; Oza, Amit M; Avall-Lundqvist, Elisabeth; Berek, Jonathan S; Ledermann, Jonathan A; Berton, Dominique; Sehouli, ... Journal: International journal of gynecological cancer Issue: Volume 32:Issue 6(2022) Page Start: 761 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗